Oxford Immunotec USA, Inc.

A global, high-growth diagnostics company who brings energy and invention to a world in need of diagnostic truth

[Oxford Immunotec USA, Inc. @OXFDImmunotec]

We’re charting a new course as part of @RevvityInc – a science-based solutions company working to help solve the world’s greatest health challenges. Follow @RevvityDX and @RevvityLifeSci for future news and updates from our team. More details here: https://t.co/CSlVr4meH4

[Revvity @RevvityInc]

Today PerkinElmer announced the completion of its divestiture of the Company’s Analytical & Enterprise Solutions business. More details on this transformation and the new, independent Life Sciences & Diagnostics business here: https://t.co/ozBatvR3t3

[Bioscience Today @biosciencetoday]

Peter Wrighton-Smith, CEO of @OxfordImmunoEUR, talks to Bioscience Today about growing understanding of the importance of #Tcells in protecting us from disease https://t.co/ecjygdwCj6

[Oxford Immunotec USA, Inc. @OXFDImmunotec]

Hear from our founder and CEO about the critical role T cells play in the immune response to viral infections

[Bioscience Today @biosciencetoday]

I think you'll be interested in this article! https://t.co/teBv0kO7h6

[Oxford Immunotec USA, Inc. @OXFDImmunotec]

We are thrilled to debut our global immunology services offering, Certimmune.

Clinical, technical, operational and regulatory support to #vaccine and #immunotherapy manufacturers in facilitating immunology testing in support of their phased #clinicaltrials

[Oxford Immunotec USA, Inc. @OXFDImmunotec]

Following World TB Day, we continue to highlight the impact that COVID-19 has had on TB services. Professor Keertan Dheda has provided us with his thoughts around this topic and more.

Read the full piece here: https://t.co/g4iNZ5bV8u

#WorldTBDay #EndTB #InvestToEndTB

[Oxford Immunotec USA, Inc. @OXFDImmunotec]

As we continue with our commitment to End TB, this infectious disease remains a serious, global public health problem with alarming facts:

Visit the link to find out more, https://t.co/Uf33pT7VRu

#WorldTBDay #EndTB #InvestToEndTB

[Oxford Immunotec USA, Inc. @OXFDImmunotec]

Have our efforts to contain #COVID19 jeopardised our chances of ending #TB?

Professor Keertan Dheda, University of Cape Town and London School of Hygiene & Tropical Medicine, has provided us with his thoughts.

Visit the link to find out more: https://t.co/Uf33pT7VRu

#EndTB

[Oxford Immunotec USA, Inc. @OXFDImmunotec]

As we continue with our commitment to End TB, TB remains a serious, global public health problem with alarming facts:

https://t.co/g4iNZ5bV8u

#WorldTBDay #EndTB #InvestToEndTB

[Oxford Immunotec USA, Inc. @OXFDImmunotec]

Each year, the global health community commemorates the day in 1882 when famed microbiologist Dr. Robert Koch first announced his discovery of Mycobacterium tuberculosis.

For additional educational resources on TB, please visit: https://t.co/0Tui9qzHol

#WorldTBDay #EndTB

[Oxford Immunotec USA, Inc. @OXFDImmunotec]

Our CEO, Peter Wrighton-Smith, highlights the importance of #TB testing on this #WorldTBDay. #COVID19 has taught us lessons on the importance of diagnostic testing to control the transmission of respiratory diseases. This is also true for TB.

[Oxford Immunotec USA, Inc. @OXFDImmunotec]

On this #WorldTBDay, we honour #TB survivors by amplifying their personal stories & echoing the call worldwide for early & accurate TB diagnosis.
Watch & learn about Tenzin’s story, on our dedicated page, as part of our WTBD, Spotlight on Survivors series.
https://t.co/g4iNZ5bV8u

[Oxford Immunotec USA, Inc. @OXFDImmunotec]

In the lead up to World TB Day, we put a spotlight on a fantastic piece by Dr Morten Ruhwald, Head of Tuberculosis at FIND.

Discover the full piece under the 'hear from the experts' section of our World TB Day page: https://t.co/Uf33pT7VRu

#WorldTBDay #EndTB #InvestToEndTB

[Oxford Immunotec USA, Inc. @OXFDImmunotec]

As we approach World TB Day, tuberculosis remains a serious, global public health problem with alarming facts:

#WorldTBDay #EndTB #InvestToEndTB

[Oxford Immunotec Europe @OxfordImmunoEUR]

How much disruption has #COVID19 really had on #TB services? @WHO Global Tuberculosis Report '21 has given cause for concern, stating that for the first time in more than a decade, TB mortality has increased.

Discover the full paper and its findings here: https://t.co/Fj1iudjzZB

[Oxford Immunotec USA, Inc. @OXFDImmunotec]

#Bettertogether

[EUROIMMUN @EUROIMMUN]

#Bettertogether

We are currently attending the #AACC2021 together with @PerkinElmer, @OXFDImmunotec and @IDSDiagnostics . We are proud to belong to a motivated and strong community of #experts.

#perkinelmer #ids #oxfordimmunotec #euroimmun #science

[Oxford Immunotec USA, Inc. @OXFDImmunotec]

We are thrilled to be attending the American Association for Clinical Chemistry's Annual Scientific Meeting & Clinical Lab Expo with @PerkinElmer and @EUROIMMUN. Visit us at booth # 840 through September 30th to learn about the advantages of the T-SPOT.TB test.

#2021AACC #AACC

[Oxford Immunotec USA, Inc. @OXFDImmunotec]

At Oxford Immunotec, we’re on a mission to bring energy and invention to a world in need of diagnostic truth. If you're looking for a rewarding career where your work matters, visit our careers page: https://t.co/rDX5Wnqt7y

#werehiring #newcareer #yourworkmatters #applytoday

[Oxford Immunotec USA, Inc. @OXFDImmunotec]

Did you know that the tuberculin skin test was developed 114 years ago? But in the early 2000's, #IGRAs were introduced to the market allowing physicians to test for #tuberculosis in just one visit using whole blood. Learn more at: https://t.co/N0AgQlNfum

#tst #ppd #tb #ltbi

[Oxford Immunotec USA, Inc. @OXFDImmunotec]

We are excited to be an exhibitor at this year's Association of Occupational Health Professionals in Healthcare conference! Visit us at booth 29 between September 8 - 10 to learn how the T-SPOT.TB test can enhance your #TB screening protocols.

#AOHP #2021AOHP #tuberculosis